Speaking of SurgOnc

https://speakingofsurgonc.libsyn.com/rss

19 Followers

60 Episodes

19
Followers

60
Episodes

Category: Science
Last Update: 2024-09-10
Claim Ownership

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

1	SSO2024 Abstract: Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods 2024-09-10	Play	Download
2	Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career Stages 2024-08-13	Play	Download
3	Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies 2024-07-16	Play	Download
4	Docetaxel‑Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15‑Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network 2024-06-11	Play	Download
5	The Landmark Series—Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women 2024-05-21	Play	Download
6	Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6 2024-04-09	Play	Download
7	Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer 2024-03-12	Play	Download
8	Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter? 2024-02-13	Play	Download
9	Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study 2024-01-09	Play	Download
10	CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer 2023-12-12	Play	Download

←
1
2
3
4
5
6
→